Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ostolief Nutra is a proprietary nutraceutical formulation developed by Charak Pharma to support joint health, flexibility, and mobility. It is a synergistic combination of phytomedicines and nutritional supplements, including glucosamine hydrochloride, chondroitin sulfate, calcium carbonate, Boswellia serrata (shallaki) gum resin extract, and Curcuma longa (haridra) rhizome extract, along with vitamins C, D3, and E. It is indicated for the management of joint pain, stiffness, and inflammation associated with mild to moderate osteoarthritis and osteoporosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ostolief Nutra.